Haemorrheological effects of prostaglandin E1 infusion in Raynaud's syndrome.

AUTOR(ES)

Lucas, G S

RESUMO

Eighteen patients with severe Raynaud's syndrome had impaired deformability of erythrocytes, as measured by filtration through 5 micron diameter pores, compared with 19 healthy controls. The patients were given prostaglandin E1 (PGE1) or placebo by intravenous infusion for 72 h to assess the haemorrheological action of PGE1. Contrary to a previous report, PGE1 did not improve erythrocyte filterability. Infusion of PGE1 did, however, evoke an acute phase response with hyperproteinaemia and a leucocytosis and is a potentially important mediator of this stress response in patients with vascular disease.

Documentos Relacionados

• A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome.
• Assessment of platelet function in patients with Raynaud's syndrome.
• Raynaud's Syndrome
• The prevalence of Raynaud's syndrome in rheumatoid arthritis.
• White blood cell activation in Raynaud's phenomenon of systemic sclerosis and vibration induced white finger syndrome.